Skip to content
MARKET METER ·· loading... Details ▾ ▾
The Clinic
  • Home
  • Mission
  • Impact
  • Research
  • Education
  • Tools
  • Testimonials
  • Scholarship
  • About
Sign in Subscribe
Research

Shorting Royal Caribbean

Royal Caribbean is a leveraged consumer-cyclical staring down fuel inflation, a K-shaped consumer, and Caribbean geopolitical risk. I'm short the Dec '26 $370 calls.

Doc Hollywood April 24, 2026 · 7 min read
Shorting Royal Caribbean

This post is for paying subscribers only

Subscribe now

Already have an account? Sign in

Members keep reading

This research is part of the membership

  • Full single-name research reports and weekly macro, in plain English
  • The complete investing curriculum, from first dollar to advanced
  • Six live tools: charts, whales, Congress, catalysts, squeezes, screens
  • 100% of membership profits donated to kids and schools
See membership options Sign in
Filed under: Research trade ideas short $RCL
Written by

Doc Hollywood

Reminder: This post is for educational and informational purposes only. Nothing here is investment advice. The author may hold positions in securities discussed. See full disclosures.

✚
Join the list

Research in your inbox.

Plain-English macro, trade ideas, and community impact reports. One email a week, no spam, ever.

Free tier available. Premium research unlocks with membership.

The ClinicResearch, education, and tools for retail investors. Profits go to kids and schools.

Become a member
The Clinic

Diagnosing markets & writing prescriptions for our community

100% of membership profits donated to kids and schools in our community.

Read

  • Home
  • Mission
  • Impact
  • Research
  • Education
  • Tools
  • Testimonials
  • Scholarship
  • About

Tools

  • Charting Desk
  • Whale Watch
  • Congress Watch
  • Catalyst Radar
  • Squeeze Scanner
  • Lynch Screener

Legal

  • Disclosures
  • Privacy
  • Terms

Join The Clinic

Private research. Community impact.

Become a member

Important Disclosure: The Clinic is an independent research publication. Content is for educational and informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. The publisher is not a registered investment adviser, broker-dealer, or financial planner. All investing involves risk, including loss of principal. Past performance does not guarantee future results. The publisher may hold positions in securities discussed. Consult a licensed financial professional before acting on anything you read here. See full Terms, Disclosures, and Risk Statement.

© 2026 The Clinic. All rights reserved. Published with Ghost.